US Patent

US9895388 — Methods and compositions useful for controlling cutaneous mites

Method of Use · Assigned to Parapro · Expires 2033-11-25 · 8y remaining

Vulnerability score 70/100 Vulnerable — likely target for IPR or design-around

What this patent protects

This patent protects methods and compositions for treating cutaneous mites using spinosyn or a physiologically acceptable derivative or salt thereof.

USPTO Abstract

The present invention relates to compositions and methods useful for the topical treatment of cutaneous mites comprising spinosyn or a physiologically acceptable derivative or salt thereof.

Drugs covered by this patent

Natroba (SPINOSAD) · Cipher

FDA Patent Use Codes

When a patent is method-of-use, FDA lists it once per applicable indication ("U-code"). Each U-code carves out a specific therapeutic use that generic filers must either license or design around.

Code	Description	Drug
`U-3365`	—	Natroba

Patent Metadata

Patent number: US9895388
Jurisdiction: US
Classification: Method of Use
Expires: 2033-11-25
Drug substance claim: No
Drug product claim: No
Assignee: Parapro
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.